Advertisement
Nuvalent, Inc.

Nuvalent, Inc. (NUVL) Stock Overview

Explore Nuvalent, Inc.โ€™s financial performance, market position, analyst ratings, and future outlook.

NUVLโ—NASDAQ
HealthcareBiotechnology
$123.41
$34.92(39.46%)
U.S. Market is Open ยท 11:58
Advertisement

Nuvalent, Inc. (NUVL)

Meyka AI Score

Z

Key Financials

Market Cap9.1B
P/E Ratio-21.52
EPS (TTM)$-6.06
ROE-0.43%
Fundamental Analysis

AI Price Forecasts

1 Month$106.48
3 Months$114.26
1 Year Target$116.77

NUVL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Nuvalent, Inc. (NUVL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 34.53, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $116.77.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -21.52 and a market capitalization of 9.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
39.28%
5-Day Change
34.94%
1-Month Change
17.07%
3-Month Change
20.46%
6-Month Change
17.28%
Year-to-Date (YTD) Change
22.53%
1-Year Change
62.001%
3-Year Change
194.72%
5-Year Change
557.33%
All-Time (Max) Change
557.33%

Contact Information

857 357 7000
One Broadway, Cambridge, MA, 02142

Company Facts

162 Employees
IPO DateJul 29, 2021
CountryUS
Actively Trading

Frequently Asked Questions